Article

Signal mining and risk analysis of the over-indications use of bevacizumab

2025-07-14

Abstract excerpt

<title>Abstract</title> <p>Objective To dig deeper into the Adverse events(ADEs) signal generated by bevacizumab in the past decade, and to compare and summarize the clinical characteristics and medication risks of the over-indications use of bevacizumab. Methods “Bevacizumab”, “ALYMSYS”, “AVASTIN”, “MVASI”, “VEGZELMA”, and “ZIRABEV” were used as search terms to extract relevant data from the FDA Adverse Event Re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aaf8de7c-6c1c-513f-9674-c98efb97be30
DOI: 10.21203/rs.3.rs-6220237/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Signal mining and risk analysis of the over-indications use of bevacizumabDOI 10.21203/rs.3.rs-6220237/v1Read

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity Read

Safety assessment of S-1: Real-world adverse event analysis from the FAERS databaseSemantic proximity Read

A Real-World Disproportionality Analysis of Two Typical First-Generation TRK Inhibitors: Findings from the FDA Adverse Event Reporting System DatabaseSemantic proximity Read

Real-World Data Analysis of Vascular and Lymphatic Adverse Events Associated with Anti-Tumor Angiogenesis Drugs: A WHO-VigiAccess StudySemantic proximity Read

Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS DatabaseSemantic proximity Read

Adverse event analysis and signal detection of calcitonin gene-related peptide inhibitors using the FDA Adverse Event Reporting System databaseSemantic proximity Read

Cutaneous adverse events associated with Rybrevant based on FDA Adverse Event Reporting System (FAERS) database from 2021 to 2024Semantic proximity Read

Pharmacovigilance analysis of inclisiran:a real-world assessment based on the FAERS databaseSemantic proximity Read

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for OsimertinibSemantic proximity Read

Adverse reactions associated with the use of ustekinumab in Crohn's disease treatment：an analysis based on the FAERS databaseSemantic proximity Read

Signal Mining and Analysis of Adverse Events of Isotretinoin: 20-year real-world pharmacovigilance analysis based on the FAERS databaseSemantic proximity Read

Pharmacovigilance study of BCR-ABL1 tyrosine kinase inhibitors: A safety analysis of the FDA Adverse Event Reporting SystemSemantic proximity Read